Literature DB >> 9496180

Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.

P T Heath1, J Bowen-Morris, D Griffiths, H Griffiths, D W Crook, E R Moxon.   

Abstract

OBJECTIVES: To assess the persistence of serum Haemophilus influenzae type b antibodies and the prevalence of H influenzae type b carriage in a group of preschool age children previously vaccinated in infancy.
DESIGN: Names were randomly selected from immunisation records. Families were visited on five occasions over a period of 12 months and throat swabs were taken from all family members present, with blood obtained from children at the first and last visits.
RESULTS: One hundred and fifty three children at a median age of 3.6 years had a geometric mean titre (GMT) of 1.06 micrograms/ml (95% CI 0.80 to 1.38). Eight per cent had an undetectable antibody concentration, received a booster dose of plain PRP vaccine, and responded with concentrations > 2 micrograms/ml. GMT at 4.5 years of age was 0.89 microgram/ml (0.69 to 1.16). Twelve children who had been exposed to H influenzae had a GMT of 4.7 v 0.8 micrograms/ml for those without exposure.
CONCLUSIONS: Accelerated immunisation against H influenzae without a second year booster results in persistence of satisfactory serum concentrations of antibody to 4.5 years of age. In those with undetectable antibody, immunological memory may still be present.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9496180      PMCID: PMC1717421          DOI: 10.1136/adc.77.6.488

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.

Authors:  R Booy; P T Heath; M P Slack; N Begg; E R Moxon
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

2.  Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.

Authors:  R Booy; S A Taylor; S R Dobson; D Isaacs; G Sleight; S Aitken; H Griffiths; H Chapel; R T Mayon-White; J A Macfarlane
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

3.  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

Authors:  J B Robbins; J C Parke; R Schneerson; J K Whisnant
Journal:  Pediatr Res       Date:  1973-03       Impact factor: 3.756

4.  Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.

Authors:  R Booy; S Hodgson; H Griffiths; H M Chapel; E R Moxon
Journal:  BMJ       Date:  1993-04-10

5.  Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.

Authors:  M L Barbour; R Booy; D W Crook; H Griffiths; H M Chapel; E R Moxon; D Mayon-White
Journal:  Pediatr Infect Dis J       Date:  1993-06       Impact factor: 2.129

6.  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  H Käyhty; H Peltola; V Karanko; P H Mäkelä
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

7.  Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.

Authors:  P H Mäkelä; H Peltola; H Käyhty; H Jousimies; O Pettay; E Ruoslahti; A Sivonen; O V Renkonen
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

8.  Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.

Authors:  G A Weinberg; M S Einhorn; A A Lenoir; P D Granoff; D M Granoff
Journal:  J Pediatr       Date:  1987-07       Impact factor: 4.406

9.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Authors:  M Santosham; M Wolff; R Reid; M Hohenboken; M Bateman; J Goepp; M Cortese; D Sack; J Hill; W Newcomer
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

10.  Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.

Authors:  A K Takala; J Eskola; M Leinonen; H Käyhty; A Nissinen; E Pekkanen; P H Mäkelä
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

View more
  9 in total

1.  Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.

Authors:  J McVernon; P D R Johnson; A J Pollard; M P E Slack; E R Moxon
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

Review 2.  The UK Hib vaccine experience.

Authors:  P T Heath; J McVernon
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

3.  Hib vaccination in infants born prematurely.

Authors:  P T Heath; R Booy; J McVernon; J Bowen-Morris; H Griffiths; M P E Slack; A C Moloney; M E Ramsay; E R Moxon
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

Review 4.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

Review 5.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 6.  Bacterial meningitis: the impact of vaccination.

Authors:  Nick Makwana; F Andrew I Riordan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Haemophilus influenzae type b reemergence after combination immunization.

Authors:  Nik G Johnson; Jens U Ruggeberg; Gail F Balfour; Y Chen Lee; Helen Liddy; Diane Irving; Joanna Sheldon; Mary P E Slack; Andrew J Pollard; Paul T Heath
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

8.  HIV-Exposed Uninfected Infants Show Robust Memory B-Cell Responses in Spite of a Delayed Accumulation of Memory B Cells: an Observational Study in the First 2 Years of Life.

Authors:  Eunice W Nduati; Irene N Nkumama; Faith K Gambo; Daniel M Muema; Miguel G Knight; Amin S Hassan; Margaret N Jahangir; Timothy J Etyang; James A Berkley; Britta C Urban
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

9.  Immunogenicity and safety of two different Haemophilus influenzae type b conjugate vaccines in Korean infants.

Authors:  Kyung Hyo Kim; Hyunju Lee; Eun Hee Chung; Jin Han Kang; Jong Hyun Kim; Jung Soo Kim; Hoan Jong Lee; Sung Hee Oh; Eun Ae Park; Su-Eun Park
Journal:  J Korean Med Sci       Date:  2008-12-23       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.